Tiziana Life Sciences (LON:TILS) Stock Passes Below 200-Day Moving Average – What’s Next?

Shares of Tiziana Life Sciences PLC (LON:TILS) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 58.50 ($0.76) and traded as low as GBX 45 ($0.58). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.76), with a volume of 297,127 shares changing hands.

Tiziana Life Sciences Price Performance

The company has a market cap of £113.85 million and a P/E ratio of -3.59. The firm’s 50-day moving average is GBX 58.50 and its two-hundred day moving average is GBX 58.50. The company has a debt-to-equity ratio of 2.36, a current ratio of 6.54 and a quick ratio of 6.41.

About Tiziana Life Sciences

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.